Latest Headlines

Melinta Therapeutics (MLNT) Receives a Higher Rating From WBB Securities. Will Other Analysts Follow Suit?

Ellis Scott

Melinta Therapeutics (MLNT) Stock Upgrade WBB Securities increased shares of Melinta Therapeutics (MLNT) stock to a “Speculative Buy” rating from their previous “Hold”. The announcement of this change was revealed in analysts note earlier today. The firm currently has a respectable $8 TP on shares. – Melinta Therapeutics, Inc. (NASDAQ:MLNT) Ratings Coverage ...